DAMPening Inflammation by Modulating TLR Signalling

被引:736
作者
Piccinini, A. M. [1 ]
Midwood, K. S. [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Fac Med, Kennedy Inst Rheumatol, London W6 8LH, England
基金
英国医学研究理事会;
关键词
TOLL-LIKE RECEPTOR; MOBILITY GROUP BOX-1; HEAT-SHOCK-PROTEIN; NEUTROPHIL ELASTASE INHIBITOR; EXTRA DOMAIN-A; BRONCHOALVEOLAR LAVAGE FLUID; N-TERMINAL DOMAIN; ACTIVATE B-CELLS; DENDRITIC CELLS; CUTTING EDGE;
D O I
10.1155/2010/672395
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Damage-associated molecular patterns (DAMPs) include endogenous intracellular molecules released by activated or necrotic cells and extracellular matrix (ECM) molecules that are upregulated upon injury or degraded following tissue damage. DAMPs are vital danger signals that alert our immune system to tissue damage upon both infectious and sterile insult. DAMP activation of Toll-like receptors (TLRs) induces inflammatory gene expression to mediate tissue repair. However, DAMPs have also been implicated in diseases where excessive inflammation plays a key role in pathogenesis, including rheumatoid arthritis (RA), cancer, and atherosclerosis. TLR activation by DAMPs may initiate positive feedback loops where increasing tissue damage perpetuates pro-inflammatory responses leading to chronic inflammation. Here we explore the current knowledge about distinct signalling cascades resulting from self TLR activation. We also discuss the involvement of endogenous TLR activators in disease and highlight how specifically targeting DAMPs may yield therapies that do not globally suppress the immune system.
引用
收藏
页数:21
相关论文
共 285 条
[1]   The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism [J].
Abeyama, K ;
Stern, DM ;
Ito, Y ;
Kawahara, K ;
Yoshimoto, Y ;
Tanaka, M ;
Uchimura, T ;
Ida, N ;
Yamazaki, Y ;
Yamada, S ;
Yamamoto, Y ;
Yamamoto, H ;
Iino, S ;
Taniguchi, N ;
Maruyama, I .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (05) :1267-1274
[2]   Cutting edge: HMG-1 as a mediator of acute lung inflammation [J].
Abraham, E ;
Arcaroli, J ;
Carmody, A ;
Wang, HC ;
Tracey, KJ .
JOURNAL OF IMMUNOLOGY, 2000, 165 (06) :2950-2954
[3]   Fibrinogen signal transduction as a mediator and therapeutic target in inflammation: Lessons from multiple sclerosis [J].
Adams, R. A. ;
Schachtrup, C. ;
Davalos, D. ;
Tsigelny, I. ;
Akassoglou, K. .
CURRENT MEDICINAL CHEMISTRY, 2007, 14 (27) :2925-2936
[4]   HMGB-1, a DNA-binding protein with cytokine activity, induces brain TNF and IL-6 production, and mediates anorexia and taste aversion [J].
Agnello, D ;
Wang, HC ;
Yang, H ;
Tracey, KJ ;
Ghezzi, P .
CYTOKINE, 2002, 18 (04) :231-236
[5]   Cutting edge: Different toll-like receptor agonists instruct dendritic cells to induce distinct th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-fos [J].
Agrawal, S ;
Agrawal, A ;
Doughty, B ;
Gerwitz, A ;
Blenis, J ;
Van Dyke, T ;
Pulendran, B .
JOURNAL OF IMMUNOLOGY, 2003, 171 (10) :4984-4989
[6]   Inflammation and structural changes in the airways of patients with atopic and nonatopic asthma [J].
Amin, K ;
Lúdvíksdóttir, D ;
Janson, C ;
Nettelbladt, O ;
Björnsson, E ;
Roomans, GM ;
Boman, G ;
Sevéus, L ;
Venge, P .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 162 (06) :2295-2301
[7]   Pivotal Advance: HMGB1 expression in active lesions of human and experimental multiple sclerosis [J].
Andersson, Asa ;
Covacu, Ruxandra ;
Sunnemark, Dan ;
Danilov, Alexandre I. ;
Dal Bianco, Assunta ;
Khademi, Mohsen ;
Wallstrom, Erik ;
Lobell, Anna ;
Brundin, Lou ;
Lassmann, Hans ;
Harris, Robert A. .
JOURNAL OF LEUKOCYTE BIOLOGY, 2008, 84 (05) :1248-1255
[8]   HMGB1 is a potent trigger of arthritis [J].
Andersson, U ;
Erlandsson-Harris, H .
JOURNAL OF INTERNAL MEDICINE, 2004, 255 (03) :344-350
[9]  
AOTSUKA S, 1988, CLIN EXP IMMUNOL, V73, P436
[10]   Novel signal transduction pathway utilized by extracellular HSP70 -: Role of Toll-like receptor (TLR) 2 AND TLR4 [J].
Asea, A ;
Rehli, M ;
Kabingu, E ;
Boch, JA ;
Baré, O ;
Auron, PE ;
Stevenson, MA ;
Calderwood, SK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (17) :15028-15034